Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

sox040713,

Thank you for the aspire financing clarification. This makes sense...

Go Leo & IPIX!

This one is too easy to refute. IPIX has enough financing for the next 12 months.

“As of September 30, 2017, we had approximately $2.9 million in cash compared to $4.1 million of cash as of June 30, 2017. We anticipate that future budget expenditures will be approximately $15 million for the next twelve months, including approximately $10 million for clinical activities, supportive research, and drug product development.”

“During the period from September 6, 2017 to September 30, 2017, the Company has generated proceeds of approximately $0.4 million under this agreement with Aspire Capital from the sale of approximately 0.6 million shares of its common stock. As of September 30, 2017, the available balance is approximately $29.6 million.”

“The Company has an effective shelf registration statement on Form S-3, registering the sale of up to $75 million of the Company’s securities. The Company filed the Form S-3 with the SEC on September 11, 2017, which included registering the shares underlying the 2017 $30 million Aspire Capital stock purchase agreement.”

https://www.sec.gov/Archives/edgar/data/1355250/000147793217005408/ipix_10q.htm

I’m glad there’s no lender so IPIX has no debt, which means they can’t file for bankruptcy.

“Bankruptcy is a legal status of a person or other entity that cannot repay debts to creditors.”

https://en.m.wikipedia.org/wiki/Bankruptcy